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1. Introduction
Head and neck cancer refers to epithelial malignancies of various parts of the orofacial region,
which include paranasal sinuses, nasal cavity, pharynx and larynx, etc. These represent about
6% of all cancer cases and account for a number of new cancer cases and cancer-related deaths
worldwide every year [1, 2]. Amongst those, oral cancer is the most common type of cancer.
Squamous cell carcinoma is the most frequent single entity, constituting 95% of all oral
malignancies [3].
Oral squamous cell carcinoma is an invasive lesion with the presence of perineural growth. It
has a significant recurrence rate and frequently metastasizes to cervical lymph nodes. Since
squamous cell carcinoma constitutes the preponderance of primary malignancies of the head
and neck, it is by far the most common tumour that spreads to the cervical nodes [4]. Reports
from the American Cancer Society indicate that, at the time of initial diagnosis, over 40% of
patients with squamous cell carcinomas of the oral cavity and pharynx present with regional
dissemination of the disease [5].
In oral cancer, tumour dissemination occurs via regional lymphatic to cervical lymph node in
a predictable and sequential fashion. Oral cancer occurring in the posterior aspect of the oral
cavity, oropharynx and inferior of the mouth tends to be associated with a higher incidence of
spread to the lymph nodes at the time of diagnosis. Ipsilateral lymph nodes metastases are
frequent. However, its spreading to contralateral nodes is more common with midline and
posterior lesions [6].
The incidence of spread is influenced by the size of the tumour. Lesions classed as T1 may
show a regional spread in 10 to 20% of cases, T2 lesions in 25 to 30% of cases and T3 to T4
tumours in 50 to 75% [6].
The determination of the presence or absence of metastases in the neck nodes is mandatory
for cancer-bearing patients. This is because the therapeutic rational and prognosis depend on
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
the staging of the cancer. It is stated that the presence of metastatic node reduces the 5-year
survival rate by 50%. Moreover, the presence of another metastatic node on the contralateral
side further reduces the survival rate by 25% [7]. Patients with metastasis need more aggressive
treatments. Therefore, it is important to assess as reliably as possible whether or not a patient
has regional lymph node metastases.
The common cause of metastatic cervical lymphadenopathy is the spread from primary
tumours in the head and neck region. However, in unusual cases, they represent secondary
tumours from primary sites below the clavicles [3]. The diagnosis of such cervical neck tumours
can be decided after a complete clinical and radiological examination, focusing on the organs
or areas where there is a high chance of an existing primary tumour.
2. Mechanism of metastases in head and neck cancer
The most deadly aspect of any cancer is its ability to spread or metastasize. Metastasis is a
complex process involving the detachment of cells from the tumour tissue, the regulation of
cell motility and invasion, and the proliferation and evasion through the lymphatic system or
blood vessels.
There are different views regarding the involvement of regional lymph nodes in metastasis.
The nearby lymph nodes in tumour-bearing hosts are considered as anatomic barriers to the
spread of tumour cells. On the contrary, another concept is that the lymphatic and lymphati‐
covenous shunts bypass the regional lymph nodes and allow both the lymphatic and haema‐
togenous dissemination of malignant cells. [8].
Cancer cells have the ability to overcome the safeguards that are present in the body for the
prevention of metastasis. It is necessary to understand what ways cancer cells have mutated
in order to circumvent the body's defences and travel freely to other locations.
2.1. Lymphatic drainage in head and neck cancer
Several important groups of lymph nodes act as first echelon nodes of the oral cavity. The first
lymph node encountered in the channel, which drains a particular submucosal or subepider‐
mal lymph capillary plexus, is called the first echelon node. This is because it is here that
pathogenic organisms or free tumour cells within the lymph fluid meet their first resistance to
travel. A sentinel lymph node is defined as the first lymph node in a regional lymphatic basin
that receives lymph flow from the primary tumour. Sentinel node imaging provides a “road
map” of the lymphatic drainage from a tumour. However, it does not provide information
regarding the presence or absence of cancer cells in those nodes.
Sometimes, lymphatic metastases do not first develop in the lymph nodes nearest to the
tumour. This is known as skip metastases. The reason for this phenomenon could be venous
lymphatic anastomoses or obliteration of lymphatics by inflammation or radiation. Due to the
obstruction of the lymphatics by tumour cells, the lymph flow is disturbed and the tumour
cells spread against the flow of the lymph. This causes retrograde metastases at unusual sites,
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for example, metastases of carcinoma prostrate to the supraclavicular nodes. It is believed that
lymph nodes in the vicinity of the tumour perform multiple roles – first, acting as an initial
barrier filter and destructing tumour cells, while later providing fertile soil for the growth of
tumour cells [9].
Cervical lymph nodes include the submental, prevascular facial and submandibular group of
lymph nodes. Deep jugular lymph nodes include the jugulodigastric, juguloomohyoid and
supraclavicular group of lymph nodes. Lymph nodes in the posterior triangle of the neck
include the accessory chain of lymph nodes. The mucosa of the upper aerodigestive tract drains
to the cervical lymph nodes in the lateral aspect of the neck. Tumours of the pharynx may drain
to the parapharyngeal and retropharyngeal lymph nodes.
The Delphian lymph node is present in the central compartment of the neck and drains the
larynx and perithyroid lymph nodes adjacent to the thyroid gland. Lymph nodes in the
tracheoesophageal groove provide primary drainage to the thyroid gland, as well as the
hypopharynx, subglottic larynx and cervical oesophagus. Lymph nodes in the anterior
superior mediastinum provide drainage to the thyroid gland and the oesophagus. Further‐
more, they serve as a secondary lymphatic basin for anatomic structures in the central
compartment of the neck. Each anatomic subgroup of lymph nodes described above specifi‐
cally serve as primary echelon lymph nodes, draining a specific site in the head and neck
region. Thus, the location of a palpable metastatic lymph node may often indicate the source
of a primary tumour [8].
2.2. Assumptions about the mechanism of metastases
Lymph node metastasis occurs by haematogenous or by lymphatic routes. The cancer mass
has the same vascularity as that of healthy tissue. Thus, the cancer cells have access to the blood
stream. The malignant cells are detached from the tumour mass and enter the body’s circula‐
tion. Once in the bloodstream, the cancer cells circulate to other parts of the body. Similarly,
the lymphatic system has channels throughout the body, like the circulatory system, through
which a malignant cell can travel and metastasize.
If the cells travel through the lymph system, they may end up in nearby lymph nodes or spread
to other organs. In circulation, the cancer cells may reach to any part of the body where they
begin to grow and form a secondary tumour mass. This spread of cancer to a new part of the
body is called metastasis. The spread of malignancy to nearby lymph nodes is called local or
regional metastasis and the spread of the tumour to a distant organ is called a distant meta‐
stasis.
Cancer cells have to go through several steps in order to spread to new parts of the body:
a. The loose cancer cells have to be able to break away from the parent tumour.
b. They have to gain entry into the bloodstream or lymph system - this can carry them to
another part of the body.
c. They have to attach to the wall of a blood vessel or lymph vessel.
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d. They need to survive in a blood vessel or lymph vessel and move through it into a new
organ.
e. Malignant cells have to emerge from a blood or lymph vessel.
f. They need to be able to multiply and grow to form secondary neoplasm at the new site.
g. They need to be able to avoid attacks from the body’s immune system.
There are various factors that may influence the mechanism of regional metastases and prevent
tumour cells from developing lymph node metastases. These are:
1. The suppression of cellular immune response, in particular T cell function [7].
2. The microvascular invasion, grade of differentiation and tumour thickness in metastases
of squamous cell carcinoma of the oral cavity [10].
3. The lymphatic vessel in and around the tumour tissue and lymph node metastasis in
patients with oral squamous cell carcinoma. The dimension of lymphatic vessels is
significantly greater in the tumour tissue than in the tumour-free tissue. This means that
the function of lymphatic vessels appear to have increased in the tumour tissue, compared
to the tumour-free tissue. This results in regional metastasis [11].
Reviews of literature recommend that there are multiple and diverse reasons for cervical
lymph node metastases in head and neck cancer. However, by any means, the careful evalu‐
ation of these metastatic regional nodes is essential for appropriate treatment and to achieve
the best outcome of the treatment. Certainly, a careful clinical examination must be carried out
at the beginning of the journey regarding the evaluation of the status of cervical lymph nodes
in head and neck cancer.
3. Clinical examination of lymph nodes in head and neck cancer
Customarily, all of the palpable cervical lymph nodes are considered as positive for regional
metastasis in oral cancer. Thus, to treat all necks by considering the significant risk of having
occult lymph node metastases is a traditional approach for the treatment of oral cancer.
However, this approach often involves the unnecessary treatment of necks that ultimately
prove to be pathologically free of cancer. Therefore, appropriate investigations should be
carried out. These will help to determine the treatment plan, prognosis and morbidity by
diminishing the possibility of unnecessary neck dissection.
The location, number, size, shape, tenderness, consistency and fixity to underlying structures
are the criteria routinely used during a clinical examination of the cervical lymph nodes.
Usually, a 1 cm size cut-off in the largest axial diameter is used for metastatic disease. However,
size is not a reliable marker of malignancy as small nodes can harbour small metastases that
do not expand the node and conversely, benign nodes can be enlarged due to hyperplasia or
inflammation. Thus, the nodes of less than 1 cm should also be carefully evaluated, particularly
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if they are in expected drainage sites of the primary tumour. In clinical practice, the size of the
lymph node is only considered useful when there is an increase in nodal size on serial
examinations in a patient with a known primary tumour, which is highly suggestive of
metastasis.
Metastatic disease can change the shape of the node by infiltrating nodal tissue and expanding
the nodal capsule. Rounded nodes are more suspicious than oval nodes. As the disease
progresses, ill-defined irregular margins in a lymph node are a sign of malignancy and may
represent an extracapsular spread of tumour.
Metastatic lymph nodes are usually painless and thus, remain undetected by the patient until
they reach considerable dimensions. Characteristically, these nodes are stony-hard and freely
movable until the tumour cells penetrate the node capsule and invade the surrounding tissue.
Then, they become fixed and the expanding tumour may amalgamate surrounding nodes into
one larger, stony-hard and fixed mass. Sometimes, the small tumours in the nasal cavities,
nasopharynx and larynx may go undetected. The only evidence of their presence is the
metastatic tumour.
Oral cavity tumours usually cause metastasis in the submandibular and upper cervical regions.
Rarely, lymph nodes in the posterior triangle may also be involved. The malignancy of the
tongue base and tonsillar fossa is often the reason for metastatic lymphadenopathy in the
posterior triangle of neck.
Figure 1. Ulceroproliferative growth with rolled edges, involving buccal and lingual vestibule and alveolar ridge in a
62-year-old male. There was a history of tobacco-lime quid keeping in the same region since 30 years of age.
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Figure 2. Showing an enlarged (4 × 4 cm), hard and fixed submandibular lymph node in a patient with a malignancy of
bucco- lingual vestibule and alveolar ridge (extra oral photograph of the same 62-year-old male, shown in Figure 1)
4. Clinical staging of cervical lymph nodes in head and neck cancer
In the 1940s, the tumour-node-metastasis (TNM) staging system was reported by Pierre
Denoix. The TNM staging system is an anatomic staging system that describes the anatomic
extent of the primary tumour, the involvement of regional lymph nodes and distant metastasis.
As head and neck cancers consist of tumours arising from a variety of anatomic sites, such as
the oral cavity, nasal cavity, paranasal sinuses, nasopharynx, oropharynx, hypopharynx,
larynx, oesophagus, thyroid gland, salivary glands, etc., and miscellaneous tumours, such as
neurogenic tumours, it is impossible to generate a uniform staging system that would be
relevant for all tumours arising in the head and neck region. In current practice, information
obtained from the clinical examination and radiologic imaging is used to assign a clinical stage
(cTNM). This is then used to stratify patients for a selection of therapy and to report outcomes
of the treatment.
For many decades, the AJCC-UICC TNM staging system has been used worldwide for staging
head and neck cancer [12, 13]. This system has been periodically revised for improvement.
According to this, the cervical lymph nodes are divided into seven levels or groups, which are
based on the extent and level of cervical nodal involvement by metastatic tumour. Although
this classification of cervical lymph nodes is commonly used, especially by surgeons and
oncologists, some important lymph nodes, such as parotid and retropharyngeal nodes, are not
included in this classification.
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Stage Criteria
Nx Regional lymph nodes cannot be assessed.
No No regional lymph node metastasis.
N1 Metastasis in a single ipsilateral lymph node, < 3 cm in greatest dimension.
N2a Metastasis in a single ipsilateral lymph node, > 3 cm but < 6 cm in greatest dimension.
N2b Metastasis in multiple ipsilateral lymph nodes, none > 6 cm in greatest dimension.
N2c Metastasis in bilateral or contralateral lymph nodes, none > 6 cm in greatest dimension.
N3 Metastasis in a lymph node > 6 cm in greatest dimension.
Table 1. N staging for all Head and neck sites except the nasopharynx and thyroid - AJCC/UICC 2002 [12, 13].
Stage Criteria
Nx Regional lymph nodes cannot be assessed.
No No regional lymph node metastasis.
N1 Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above thesupraclavicular fossa. *
N2 Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above thesupraclavicular fossa. *
N3 Metastasis in a lymph node(s) > 6 cm and/or to supraclavicular fossa.
N3a Greater than 6 cm in dimension.
N3b Extension to the supraclavicular fossa. *
*Midline nodes are considered ipsilateral nodes.
Table 2. N staging for tumours of the nasopharynx - AJCC/UICC 2002 [12, 13].
Stage Criteria
Nx Regional lymph nodes cannot be assessed.*
No No regional lymph node metastasis.
N1 Regional lymph node metastasis.
N1a Metastasis to Level VI (pretracheal, paratracheal and prelaryngeal/Delphian lymph nodes).
N1b Metastasis to unilateral, bilateral, or contralateral cervical or superior mediastinal lymph nodes.
*Regional nodes are the central compartment, lateral cervical, and upper mediastinal lymph nodes.
Table 3. N staging for tumours of the thyroid - AJCC/UICC 2002 [12, 13].
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The TNM staging system is widely used to assess prognosis, determine treatment and compare
results from different protocols. However, it has a few pitfalls. The palpable lymph node in
the neck does not always mean that it is metastatic and a non-palpable does not always mean
that it is non-metastatic. They may contain micrometastases and may be discovered on a
histological examination, which were thought to be normal on palpation and imaging.
One or more non-painful nodes in asymptomatic patients or patients with an already diag‐
nosed malignancy in the T1-T2 stage in satellite or non-satellite locations are considered as
risky nodes. Furthermore, in patients with an already diagnosed malignancy in the T3-T4 stage,
three or more > 2 cm nodes in a satellite location are called end–stage nodes [14].
TNM staging systems are based on clinical findings. However, imaging should be a necessary
part of this staging or it should always be used to support the staging. If the imaging comple‐
ments the clinical examination, the following staging conversions can occur: N0 will become
N1 neck, N1 will become N2 neck, N1 will become N3c neck or N0 will become N3c neck [15].
5. Diagnosis and investigations for metastatic lymph nodes in head and
neck cancer
Imaging plays an important role in the evaluation of disease in the cervical lymph nodes and
should be a part of any thorough workup of patients with head and neck cancer. The contin‐
uous advances in techniques have led to the increased sensitivity of the imaging modalities in
the detection of lymph nodes. Various imaging techniques are used for the detection of
enlarged nodes, including ultrasound, Colour Doppler ultrasound, computed tomography,
magnetic resonance imaging positron emission tomography (PET), lymphoscintigraphy and
USG-guided fine-needle cytology, etc. Each imaging modality has advantages and disadvan‐
tages [16].
5.1. Ultrasound and colour doppler ultrasound examination of neck in head and neck cancer
Ultrasound (US)  is  a  non-invasive,  easily  accessible  and comparatively cheaper  imaging
modality, which is used for the evaluation of cervical lymphadenopathy. The sonologist is
often the first person to identify the presence of an abnormal node. Several studies have
shown that  sonography has  a  markedly  higher  sensitivity  than palpation for  the  detec‐
tion of  enlarged lymph nodes in patients  with suspected regional  lymph node metasta‐
ses, particularly in the presence of severe postoperative scarring. The use of sonography
also allows the assessment of the infiltration of blood vessels and organs, such as the thyroid
gland,  by  adjacent  nodal  metastases  and  an  accurate  follow-up  of  patients  receiving
chemotherapy or radiation therapy [17].
The AJCC classification for cervical lymph nodes in head and neck cancer is not specific for
the ultrasound examination. This is because some lymph nodes in the classification, such as
prelaryngeal, paratracheal and upper mediastinal nodes, may not be accessible via ultrasound.
In 1986, Hajek et al. established another classification of cervical lymph nodes in order to
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simplify ultrasound examinations of the neck. According to this, the cervical lymph nodes are
classified into eight regions based on their location in the neck, as shown in Figure 3 [18].
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Figure 3. Classification of cervical lymph nodes for US examination [18].
In an ultrasound examination of neck lymphadenopathy, the distribution, size, shape, nodal
border, echogenic hilus, intranodal necrosis and calcification are the evaluated features.
The size of normal cervical lymph nodes differs with the location in the various regions of the
neck and thus, it cannot be used as an absolute criterion for the diagnosis of metastatic
lymphadenopathy. The inflammatory nodes can be as large as malignant nodes, whilst a
malignancy can be found in small nodes. It has been reported that the lymph nodes in the
upper neck tend to be larger than those in the lower neck.
The shape of lymph nodes is usually assessed by the short axis diameter: long axis diameter
(S:L ratio). A lymph node with an S:L ratio less than 0.5 is oval in shape, whereas an S:L ratio
greater than or equal to 0.5 indicates round node. An oval node indicates normality, whereas
malignant nodes tend to be round in shape as shown in Figure 4 and 5.
There is a difference in the border of malignant and reactive or normal nodes. The metastatic
and lymphomatous nodes have sharp borders, whereas unsharp borders are seen in reactive
or normal nodes. The presence of a sharp border in malignant nodes is believed to be due to
the infiltrating tumour cells replacing the normal intranodal lymphoid tissue. This causes an
increase in the acoustic impedance difference between the lymph nodes and surrounding
tissues.
As far as the presence of hilum is concerned, the absence of it in a lymph node is a sign of
metastasis or malignant lymphadenopathy, as shown in Figure 6 and 7.
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In an ultrasound examination of lymph nodes, sonologists examine intranodal necrosis and
calcification. However, these examinations contribute little to the diagnosis of malignant
characteristics of lymph nodes. The reason for this is that intranodal necrosis may be present
in other conditions like tuberculous lymphadenopathy. Similarly, intranodal calcification also
does not aid the diagnosis of malignant lymphadenopathy. This is because there are other well
known causes of lymph node calcification including BCG vaccination, sarcoidosis, cat scratch
disease, tuberculosis, lymphoma and fungal infections, which have been previously treated
with radiation therapy.
 
 
         
Figure 4. Sonogram showing oval reactive lymph nodes.
 
 
                     
Figure 5. Sonogram showing round metastatic or malignant lymph node.
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One of the advancements in ultrasonography, Colour Doppler ultrasound, can be used to
define the morphologic and vascular characteristics of lymphadenopathies. Colour Doppler
sonography provides information about the presence of intranodal vascularity and estimates
the intravascular resistance. In Colour Doppler sonography, the pattern of vascular flow and
presence of high intranodal vascular resistance have been used as key features to differentiate
benign from malignant nodes.
The status of the vasculature of the lymph nodes provides additional information in the
sonographic examination of cervical lymph nodes. The vascularity of the lymph node gives
direction for diagnosing the cause of lymphadenopathy. This is because vascularity is directly
related to the actual pathology present within the lymph node.
 
 
                   
 
Figure 6. Sonogram depicting intact hilum suggestive of benign lymph node.
 
 
 
Figure 7. Sonogram showing metastatic lymph node depicting absence of hilum.
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The characteristic event in tumour formation is angiogenesis. The morphologic and haemo‐
dynamic changes that occur in tumour vessels help to differentiate between malignant and
benign lymph nodes in a Colour Doppler evaluation. In malignant or metastatic nodes,
vascular structures are usually deformed due to the destruction caused by tumour infiltration
and neovascularization induced by angiogenesis factor [19].
Tumour neovascularity has a particular set of characteristics. The vessels in the tumour are
abnormal and show an irregular course without the progressive diminution in calibre.
Furthermore, they may demonstrate arteriovenous shunting and bizarre thin walled vessels
lined by tumour cells may end in amorphous spaces. The characteristic feature of tumours
stimulating the growth of new vessels assists in the evaluation of metastatic nodes via Doppler
sonography. The tumour vessels have a relative paucity of smooth muscle in their walls,
compared to their calibre. This lack of muscular elements is reflected in the low impedance to
flow, leading to a high diastolic flow and, in some tumours, the absence of systolic/diastolic
flow variation [19, 20].
Both the angioarchitecture and haemodynamic differ among various cervical nodal diseases.
Blood vessel morphology in metastatic nodes is usually deranged as internal nodal architec‐
ture, which is destroyed by neoplastic infiltration. Small arteries in metastatic nodes may be
destroyed by tumour tissue, whereas inflammation causes the dilatation of intranodal vessels
due to local humoral agents. All of these intranodal vascular alterations aid in the differentia‐
tion of malignant lymph nodes by CDUS. This is because reactive or benign nodes tend to have
prominent hilar/central vascularity and metastatic or malignant nodes have peripheral or no
vascularity [21]. See Figure 8 and 9.
 
 
 
 
 
Figure 8. Color Doppler sonogram showing a lymph node with central vascular flow.
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Figure 9. Color Doppler sonogram showing a lymph node with absence of vascular flow.
In advanced stages of the disease, tumour cells grow and replace a large portion of the lymph
node. When the lymph node is totally replaced by the tumour cells, the tumour cells compress
vessels in the lymph node. This vascular compression by the tumour cells increases vascular
resistance, causing an increase in resistive index. These higher resistive indices can be observed
in the metastatic/malignant lymph nodes by CDUS [21], as shown in Figure 10.
 
 
 
Figure 10. Colour Doppler sonogram with Doppler spectral waveform, showing a malignant cervical lymph node with
peripheral Colour Doppler flow and a high resistivity index and pulsatility index.
Although Colour Doppler evaluation cannot replace the histopathological procedure in
knowing the status of cervical lymphadenopathy, it plays a definite role as an adjunct to the
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clinical evaluation of cervical lymphadenopathy and proves its value as an important inves‐
tigation [22].
5.2. Role of CT or MRI in diagnosis of local metastases in head and neck cancer
The radiographic evaluation of the status of lymph nodes is routinely performed on the basis
of size, morphology, shape and margins of the nodes.
Several studies have described the radio-morphologic characteristics of lymph node metasta‐
ses in computed tomography (CT) and in magnetic resonance imaging (MRI). In computed
tomography, the presence of a central hypodensity in a lymph node metastasis of a squamous
epithelial carcinoma is considered a sign of nodal necrosis. In magnetic resonance imaging, a
central necrosis appears in the T1-weighted as a central hypointensity and in the T2-weighted
image as a central hyperintensity [23].
On a CT and MRI, axial scans are usually performed. These only demonstrate the nodes in the
transverse plane, where they tend to appear round or oval. Although images can be recon‐
structed to coronal and sagittal plane, it is time consuming and in a CT, the resolution of images
is usually lower. Nodal shape does not have any value in the differentiation of reactive from
malignant nodes on a CT and MRI [24].
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Figure 11. A CT scan of a skull with contrast reveals: homogenously enhancing lesion present in the left buccinator
space, left submandibular and left jugulodigastric region lymphadenopathy. These are suggestive of a malignant le‐
sion.
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It is important to estimate the status of regional lymph nodes in cancer of any body part. In
head and neck cancer, various imaging modalities should also be performed for the detection
of local metastases. This is because imaging is more accurate than clinical examination.
However, the assessment of nodal disease by imaging can be challenging for the radiologist.
This is because there are multiple sites to review and differing opinions regarding the criteria
for abnormal nodes. Hoang et al. [25] have mentioned a systematic four-step approach for the
evaluation of metastatic cervical lymph nodes on cross-sectional neck imaging.
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Figure 12. MRI reveals intense enhancing soft tissue mass involving gingiva, alveolus, submandibular gland and man‐
dible suggestive of malignant lesion. It also reveals well-defined enhancing soft tissue lesion suggestive of lymphaden‐
opathy (Axial view - T2-weighted image).
In doubtful cases of CT or MRI criteria, ultrasound is an excellent second-line tool, which can
be used for evaluating these suspicious nodes and can also guide fine-needle aspiration to
obtain cytology.
In oncology, the use of 18-fluorodeoxyglucose (FDG) PET has grown rapidly. This is a
metabolic imaging tool that provides information beyond the anatomical constraints of
conventional imaging. It can establish whether or not enlarged lymph nodes contain a tumour
or are reactive. In 2005, Hain stated that PET has found more than 40% of metastases in lymph
nodes smaller than 1 cm. However, the disadvantage of PET is that false positives can be found
in infected nodes [26].
Kubicek et al. stated that PET and PET/CT scans have the potential to improve treatment
outcomes by providing improved lymph node staging and prognostic factors [27].
Lymphoscintigraphy has been used to evaluate lymph node function. It is less invasive for
delineating drainage and can help to visualize changes in the function [28].
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Elsewhere in the body, lymphangiography and lymphoscintigraphy are useful as these
investigations provide a combination of anatomic and physiological information about lymph
nodes. However, these are of no use in the neck. Both of these are invasive and can be
technically difficult. MR imaging performed after the administration of superparamagnetic
iron oxide particles, another hybrid of anatomic and physiological assessment, has still not
been fully evaluated and is not widely available. Metabolic (functional or physiological)
imaging with fluorine-18-fluorodeoxyglucose positron emission tomography is new and
promising. The limited anatomic detail that positron emission tomography provides will likely
require correlation with CT or MR imaging to make it widely useful.
Several studies suggested that new and highly sensitive investigations, in particular immu‐
nohistochemistry, molecular analysis, polymerase chain reaction (PCB) and serial sectioning
of cervical lymph nodes, have increased the detection rate of micrometastases in head and neck
cancers [29].
In addition to imaging techniques, the use of biomarkers studied on a protein, DNA or RNA
level may be useful for the assessment of regional metastasis in head and neck squamous cell
carcinoma [30].
FNAC and biopsy are considered confirmatory tests for the diagnosis of lymphadenopathy
but these have a certain lacunae. For example, Ying et al. [18] stated in their review that it is
difficult to collect adequate tissue volume from small lymph nodes and from post-irradiation
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Figure 13. MRI reveals intense enhancing soft tissue mass involving gingiva, alveolus, submandibular gland and man‐
dible, suggestive of a malignant lesion. It also reveals a well-defined enhancing soft tissue lesion, suggestive of lym‐
phadenopathy (coronal view - T1-weighted image).
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nodes. According to them, it has been reported that 15% of specimens from US guided FNA
did not provide an accurate diagnosis due to an uncertain diagnosis or inadequate sample. In
the neck, FNA is usually difficult in a lymph node that is situated in the deep submandibular
area.
Sato et al. [31] stated that puncturing the metastatic node with a needle could not be indicated
in all situations because of the risks of micro dissemination of cancer cells, rupture of the
capsule of the metastatic node and infection after FNAB.
6. Treatment related significance of cervical lymphadenopathy in head and
neck cancer
Localized tumours that do not metastasize have the best prognosis. Cancers that have
metastasized usually indicate a later stage disease and treatment becomes more complicated,
with poorer outcomes. During the surgical treatment of a tumour, the nearby lymph nodes are
also removed. This is because these are frequently the first sites of the cancer metastasis.
Current treatment strategies in oral cancer rely on staging based on the imaging techniques to
detect regional metastasis. However, no strategies challenge the gold standard of histopatho‐
logical examination of the neck dissection [32]. Nevertheless, various imaging madalities may
direct the surgeons to convert the treatment plan to choose a more conservative neck dissection
or, after frozen section control, to convert the treatment to a more radical dissection.
In conclusion, the presence of local metastases influences the treatment and prognosis of head
and neck cancer. The traditional approach of treating all necks by considering the significant
risk of having occult lymph node metastases may result in the unnecessary removal of regional
lymph nodes, which ultimately prove to be pathologically free of cancer. Imaging plays a vital
role in detecting the status of regional lymph nodes. For each and every patient of head and
neck cancer, pretreatment imaging should be a protocol used to help to decide the appropriate
treatment. Imaging performed before surgical treatment will aid in reducing mortality and
morbidity.
7. Conclusion
In conclusion, the traditional approach in head neck cancer is to treat all necks by consider‐
ing the significant risk of having occult lymph node metastases. Unfortunately, this ap‐
proach often involves the unnecessary treatment of necks that ultimately prove to be
pathologically free of cancer. So, we recommend the policy that for each and every patient
of head and neck cancer, careful thorough evaluation should be performed by means of var‐
ious imaging modalities. This will help to decide most appropriate treatment as well as re‐
duce overall morbidity.
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